Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Gamma Interferon Therapy for Chronic Hepatitis C [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating gamma interferon therapy for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gamma interferon (interferon gamma)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED